VanEck Vectors Biotech ETF (NASDAQ:BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund’s benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

finviz dynamic chart for BBH

Fund Overview

  • YTD Daily Total Return: 13.49%
  • Expense Ratio: 0.35%
  • Annual Dividend Yield: 0.30%
  • Three-Month Average Daily Volume: 15,785
  • Assets Under Management: $574.36 million
  • Inception Date: Dec. 20, 2011
  • Issuer: VanEck

Performance Overview

  • 13.49% YTD Daily Total Return
  • 22.84% 1-Year Daily Total Return
  • 18.32% 3-Year Daily Total Return

BBH tracks the MVIS US Listed Biotech 25 Index, an index of companies involved in the development and production, sales, and marketing of therapies based on genetic analysis and diagnostic equipment. The fund is highly concentrated in a few names, with the top 10 of its 24 holdings accounting for more than 60% of all invested assets.

Top 10 Holdings (54.41% of Total Assets)

NameSymbol% Assets
Amgen IncAMGN8.78%
Moderna IncMRNA5.92%
Gilead Sciences IncGILD5.41%
Illumina IncILMN5.32%
Regeneron Pharmaceuticals IncREGN5.22%
Alexion Pharmaceuticals IncALXN5.00%
IQVIA Holdings IncIQV4.94%
Charles River Laboratories International IncCRL4.64%
Vertex Pharmaceuticals IncVRTX4.60%
Exact Sciences CorpEXAS4.58%

Therefore, VanEck Vectors Biotech ETF is best for investors who are interested of holding top biotech stocks.

One Comment to “The Best Biotech ETF (BBH)”

Post Comment